Table of Contents Author Guidelines Submit a Manuscript
Journal of Pharmaceutics
Volume 2014 (2014), Article ID 795371, 12 pages
http://dx.doi.org/10.1155/2014/795371
Research Article

Development of Budesonide Loaded Biopolymer Based Dry Powder Inhaler: Optimization, In Vitro Deposition, and Cytotoxicity Study

Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune, Maharashtra 411038, India

Received 25 February 2014; Revised 2 May 2014; Accepted 18 May 2014; Published 15 June 2014

Academic Editor: Fabiana Quaglia

Copyright © 2014 Ashwin J. Mali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. H. Morice, S. Peterson, O. Beckman, and D. Osmanliev, “Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma,” International Journal of Clinical Practice, vol. 61, no. 11, pp. 1874–1883, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Lähelmä, M. Kirjavainen, M. Kela et al., “Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method,” British Journal of Clinical Pharmacology, vol. 59, no. 2, pp. 167–173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. N. A. Hanania, “The impact of inhaled corticosteroid and long-acting β-agonist combination therapy on outcomes in COPD,” Pulmonary Pharmacology and Therapeutics, vol. 21, no. 3, pp. 540–550, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. R. Naikwade, A. N. Bajaj, P. Gurav, M. M. Gatne, and P. Singh Soni, “Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study,” AAPS PharmSciTech, vol. 10, no. 3, pp. 993–1012, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Yang, J. I. Peters, and R. O. Williams III, “Inhaled nanoparticles—a current review,” International Journal of Pharmaceutics, vol. 356, no. 1-2, pp. 239–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Fu, J. Fiegel, E. Krauland, and J. Hanes, “New polymeric carriers for controlled drug delivery following inhalation or injection,” Biomaterials, vol. 23, no. 22, pp. 4425–4433, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Sebti, G. Pilcer, B. Van Gansbeke et al., “Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 64, no. 1, pp. 26–32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Pilcer, F. Vanderbist, and K. Amighi, “Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery,” International Journal of Pharmaceutics, vol. 365, no. 1-2, pp. 162–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Kumaresan, N. Subramanian, M. Gover Antoniraj, and K. Ruckmani, “Dry powder inhaler—formulation aspects,” Pharma Times, vol. 44, no. 10, pp. 14–18, 2012. View at Google Scholar · View at Scopus
  10. G. Saint-Lorant, P. Leterme, A. Gayot, and M. P. Flament, “Influence of carrier on the performance of dry powder inhalers,” International Journal of Pharmaceutics, vol. 334, no. 1-2, pp. 85–91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Steckel and N. Bolzen, “Alternative sugars as potential carriers for dry powder inhalations,” International Journal of Pharmaceutics, vol. 270, no. 1-2, pp. 297–306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. W. S. Cheow, S. Li, and K. Hadinoto, “Spray drying formulation of hollow spherical aggregates of silica nanoparticles by experimental design,” Chemical Engineering Research and Design, vol. 88, no. 5-6, pp. 673–685, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. N. El-Gendy, E. M. Gorman, E. J. Munson, and C. Berkland, “Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution,” Journal of Pharmaceutical Sciences, vol. 98, no. 8, pp. 2731–2746, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. F. J. Ahmad, G. Mittal, G. K. Jain, G. Malhotra, R. K. Khar, and A. Bhatnagar, “Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 71, no. 2, pp. 282–291, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. C. Sung, B. L. Pulliam, and D. A. Edwards, “Nanoparticles for drug delivery to the lungs,” Trends in Biotechnology, vol. 25, no. 12, pp. 563–570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. H. W. Frijlink and A. H. de Boer, “Dry powder inhalers for pulmonary drug delivery,” Expert Opinion on Drug Delivery, vol. 1, no. 1, pp. 67–86, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Hickey, H. M. Mansour, M. J. Telko et al., “Physical characterization of component particles included in dry powder inhalers—I. Strategy review and static characteristics,” Journal of Pharmaceutical Sciences, vol. 96, no. 5, pp. 1282–1301, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Divey, C. U. Yurteri, R. A. Grable, and M. K. Mazumder, “Effect of Charge on the deposition of electrostatically charged inhalable aerosol in lung model,” Journal of the Arkansas Academy of Science, vol. 56, pp. 146–152, 2002. View at Google Scholar
  19. M. J. Telko, J. Kujanpää, and A. J. Hickey, “Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI),” International Journal of Pharmaceutics, vol. 336, no. 2, pp. 352–360, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Alipour, H. Montaseri, and M. Tafaghodi, “Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery,” Colloids and Surfaces B: Biointerfaces, vol. 81, no. 2, pp. 521–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. De and D. Robinson, “Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres,” Journal of Controlled Release, vol. 89, no. 1, pp. 101–112, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. B. C. Lehtovaara, M. S. Verma, and F. X. Gu, “Synthesis of curdlan-graft-poly(ethylene glycol) and formulation of doxorubicin-loaded core-shell nanoparticles,” Journal of Bioactive and Compatible Polymers, vol. 27, no. 1, pp. 3–17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. J. Son and H. S. Yoo, “PH-responsive microspheres encapsulated with iron oxide nanoaggregates for gastrointestinal delivery,” Journal of Bioactive and Compatible Polymers, vol. 27, no. 1, pp. 54–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. U. H. Park, E. J. Lee, J. N. Knowles, and H. W. Kim, “Preparation of in situ hardening composite microcarrier: calcium phosphate cement combined with alginate for bone regeneration,” Journal of Biomaterials Applications, vol. 28, pp. 1079–1084, 2014. View at Google Scholar
  25. B. Witold, M. Kucharska, T. Ciach, L. Koperski, Z. Jastrzębski, and M. Szałwiński, “Bone regeneration potential of the new chitosan-based alloplastic biomaterial,” Journal of Biomaterials Applications, vol. 28, pp. 1060–1068, 2014. View at Google Scholar
  26. J. Malakar and A. K. Nayak, “Formulation and statistical optimization of multiple-unit ibuprofen-loaded buoyant system using 23-factorial design,” Chemical Engineering Research and Design, vol. 90, no. 11, pp. 1834–1846, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Rajaonarivony, C. Vauthier, G. Couarraze, F. Puisieux, and P. Couvreur, “Development of a new drug carrier made from alginate,” Journal of Pharmaceutical Sciences, vol. 82, no. 9, pp. 912–917, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Kristó, J. Bajdik, and K. Pintye-Hódi, “Optimization of the formulation of solid multiparticulate dosage forms containing pancreatin,” Chemical Engineering Research and Design, vol. 88, no. 8, pp. 1033–1036, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Gilani, A. R. Najafabadi, M. Darabi, M. Barghi, and M. Rafiee-Tehrani, “Influence of formulation variables and inhalation device on the deposition profiles of cromolyn sodium dry powder aerosols,” Daru, vol. 12, no. 3, pp. 123–130, 2004. View at Google Scholar · View at Scopus
  30. K. Iida, Y. Hayakawa, H. Okamoto, K. Danjo, and H. Leuenberger, “Evaluation of flow properties of dry powder inhalation of salbutamol sulfate with lactose carrier,” Chemical and Pharmaceutical Bulletin, vol. 49, no. 10, pp. 1326–1330, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. R. S. Dhumal, S. V. Biradar, A. R. Paradkar, and P. York, “Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery,” International Journal of Pharmaceutics, vol. 368, no. 1-2, pp. 129–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Abbas, M. Srour, P. Tang, H. Chiou, H.-K. Chan, and J. A. Romagnoli, “Sonocrystallisation of sodium chloride particles for inhalation,” Chemical Engineering Science, vol. 62, no. 9, pp. 2445–2453, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. R. C. Nagarwal, R. Kumar, and J. K. Pandit, “Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye,” European Journal of Pharmaceutical Sciences, vol. 47, no. 4, pp. 678–685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Möbus, J. Siepmann, and R. Bodmeier, “Zinc-alginate microparticles for controlled pulmonary delivery of proteins prepared by spray-drying,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 81, no. 1, pp. 121–130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Patil, A. Pawar, and S. K. Sahoo, “Effect of additives on the physicochemical and drug release properties of pioglitazone hydrochloride spherical agglomerates,” Tropical Journal of Pharmaceutical Research, vol. 11, no. 1, pp. 18–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Simonoska Crcarevska, M. Glavas Dodov, and K. Goracinova, “Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 68, no. 3, pp. 565–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. R. K. Das, N. Kasoju, and U. Bora, “Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 6, no. 1, pp. e153–e160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Andrade, F. Goycoolea, D. A. Chiappetta, J. das Neves, A. Sosnik, and B. Sarmento, “Chitosan-grafted copolymers and chitosan-ligand conjugates as matrices for pulmonary drug delivery,” International Journal of Carbohydrate Chemistry, vol. 2011, Article ID 865704, 14 pages, 2011. View at Publisher · View at Google Scholar
  39. B. Chellampillai and A. P. Pawar, “Andrographolide, a novel bioactive phytoconstituent encapsulated in sustained release biodegradable nanoparticles,” International Journal of Nanotechnology, vol. 8, no. 8-9, pp. 764–778, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. L. F. Zhang, D. J. Yang, H. C. Chen et al., “An ionically crosslinked hydrogel containing vancomycin coating on a porous scaffold for drug delivery and cell culture,” International Journal of Pharmaceutics, vol. 353, no. 1-2, pp. 74–87, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. S. Hassan and R. Lau, “Inhalation performance of pollen-shape carrier in dry powder formulation: effect of size and surface morphology,” International Journal of Pharmaceutics, vol. 413, no. 1-2, pp. 93–102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. M. J. Telko and A. J. Hickey, “Dry powder inhaler formulation,” Respiratory Care, vol. 50, no. 9, pp. 1209–1227, 2005. View at Google Scholar · View at Scopus
  43. S. P. Newman, D. Pavia, F. Moren, N. F. Sheahan, and S. W. Clarke, “Deposition of pressurised aerosols in the human respiratory tract,” Thorax, vol. 36, no. 1, pp. 52–55, 1981. View at Google Scholar · View at Scopus
  44. X. Kou, L. W. Chan, H. Steckel, and P. W. S. Heng, “Physico-chemical aspects of lactose for inhalation,” Advanced Drug Delivery Reviews, vol. 64, no. 3, pp. 220–232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Saigal, W. K. Ng, R. B. H. Tan, and S. Y. Chan, “Development of controlled release inhalable polymeric microspheres for treatment of pulmonary hypertension,” International Journal of Pharmaceutics, vol. 450, no. 1-2, pp. 114–122, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Harush-Frenkel, M. Bivas-Benita, T. Nassar et al., “A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery,” Toxicology and Applied Pharmacology, vol. 246, no. 1-2, pp. 83–90, 2010. View at Publisher · View at Google Scholar · View at Scopus